TRIM29, a member of the group of RING-less TRIMs, acts as a tumor promoting factor in CRC as implicated by the fact that increased expression levels of TRIM29 observed in CRC patient specimens positively correlates with lymph node metastasis. Here, TRIM29 is linked to neoplasm.